Signia Therapeutics is an innovative French start-up company.
Signia Therapeutics has raised $1.9M in total funding. The most recent round was Grant. The last funding was announced in January 2022.
Signia Therapeutics's investors include Bpifrance, EISMEA, Neovacs.
Signia Therapeutics is headquartered in Lyon, France.
Signia Therapeutics is an innovative French start-up company.
Signia Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Signia Therapeutics — Funding & Investors." VCBacked, January 4, 2022, https://www.vcbacked.co/company/signia-therapeutics. Accessed November 12, 2026.
VCBacked. (2022). Signia Therapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/signia-therapeutics
{{cite web |title=Signia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/signia-therapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Signia Therapeutics? Request a listing update